Dyne Therapeutics, Inc. DYN Market capitalization

Market capitalization at other companies

Sarepta Therapeutics, Inc.SRPT

$1.9B+1.7%

Ionis PharmaceuticalsIONS

$13.1B+108%

Arrowhead ResearchARWR

$8.78B+402%

Wave Life SciencesWVE

$1.12B+5.2%

Solid Biosciences Inc.SLDB

$983.51M+161%

Edgewise Therapeutics, Inc.EWTX

$3.38B+61.3%

FAQ

What is Dyne Therapeutics, Inc.'s market capitalization?

Dyne Therapeutics, Inc. (DYN) reported market capitalization of $2.99B in Q1 2026.

How has Dyne Therapeutics, Inc.'s market capitalization changed year-over-year?

Dyne Therapeutics, Inc.'s market capitalization increased by 152.9% year-over-year, from $1.18B to $2.99B.

What is the long-term trend for Dyne Therapeutics, Inc.'s market capitalization?

Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s market capitalization has grown at a 25.4% compound annual growth rate (CAGR), from $1.04B to $3.22B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.